نتایج جستجو برای: suberoylanilide hydroxamic acid saha

تعداد نتایج: 748959  

2006
NAOKI KOMATSU NORIHIKO KAWAMATA SEISHO TAKEUCHI DONG YIN WENWEN CHIEN CARL W. MILLER PHILLIP KOEFFLER

Current chemotherapy of advanced non-small cell lung cancer (NSCLC) produces only a modest increase in survival time. New approaches are needed for this disease. The development of lung cancer is associated with silencing tumor suppressor genes that can occur not only by deletion or mutation, but also by epigenetic changes including histone deacetylation of key lysines. Histone deacetylase inhi...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2003
Emma Hockly Victoria M Richon Benjamin Woodman Donna L Smith Xianbo Zhou Eddie Rosa Kirupa Sathasivam Shabnam Ghazi-Noori Amarbirpal Mahal Philip A S Lowden Joan S Steffan J Lawrence Marsh Leslie M Thompson Cathryn M Lewis Paul A Marks Gillian P Bates

Huntington's disease (HD) is an inherited, progressive neurological disorder that is caused by a CAG/polyglutamine repeat expansion and for which there is no effective therapy. Recent evidence indicates that transcriptional dysregulation may contribute to the molecular pathogenesis of this disease. Supporting this view, administration of histone deacetylase (HDAC) inhibitors has been shown to r...

Journal: :Molecular medicine reports 2015
Xiujun Han Shibing Wang Wenjing Zhou Ying Li Wen Lei Weiguo Lv

Oncolytic adenoviruses (OA) have been investigated as virotherapeutic agents for the treatment of cervical cancer and thus far results are promising. However, the cytotoxicity of the viruses requires improvement. The present study demonstrated that this can be achieved by combining ZD55-TRAIL, an OA containing the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene, with the hi...

Journal: :Molecular cancer research : MCR 2012
Xufeng Chen Patty Wong Eric H Radany Jeremy M Stark Corentin Laulier Jeffrey Y C Wong

Histone deacetylase inhibitors (HDI) have shown promise as candidate radiosensitizers for many types of cancers. However, the mechanisms of action are not well understood, and whether they could sensitize multiple myeloma (MM) to radiation therapy is unclear. In this study, we show that suberoylanilide hydroxamic acid (SAHA) at low concentrations has minimal cytotoxic effects, yet can significa...

Journal: :Anticancer research 2011
Bruce C Casto Michael A Pereira

BACKGROUND Concurrent and sequential administration of combinations of budesonide, bexarotene, suberoylanilide hydroxamic acid (SAHA) and atorvastatin were evaluated in A/J mice for prevention of lung tumors initiated by 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanol, NNK). MATERIALS AND METHODS Individual drugs and their combinations were administered for 26 weeks after NNK initiation. For s...

Journal: :International journal of oncology 2008
Patrizia Portanova Tiziana Russo Ornella Pellerito Giuseppe Calvaruso Michela Giuliano Renza Vento Giovanni Tesoriere

Histone deacetylase inhibitors (HDACIs) activate genes that promote cell cycle arrest and apoptosis in a number of tumor cells. This study showed that suberoylanilide hydroxamic acid (SAHA), a potent and commonly used HDACI, induced apoptosis in human colon adenocarcinoma HT-29 cells in a time- and dose-dependent manner. This effect was accompanied by the induction of oxidative stress, dissipat...

2015
Yingjie Zhang Xiaoguang Li Jinning Hou Yongxue Huang Wenfang Xu

In our previous research, a novel series of histone deacetylase (HDAC) inhibitors with L-phenylglycine scaffold were designed and synthesized, among which amides D3 and D7 and ureido D18 were far superior to the positive control (suberoylanilide hydroxamic acid [SAHA]) in HDAC inhibition, but were only comparable to SAHA in antiproliferation on tumor cell lines. Herein, further structural deriv...

Journal: :Cancer letters 2010
Zhihua An Christian B Gluck Megan L Choy Laura J Kaufman

High grade gliomas are aggressive cancers that are not well addressed by current chemotherapies, in large measure because these drugs do not curtail the diffuse invasion of glioma cells into brain tissue surrounding the tumor. Here, we investigate the effects of suberoylanilide hydroxamic acid (SAHA) on glioma cells in 2D and 3D in vitro assays, as SAHA has previously been shown to significantl...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2002
Flavio Leoni Andrea Zaliani Giorgio Bertolini Giulia Porro Paolo Pagani Pietro Pozzi Giancarlo Donà Gianluca Fossati Silvano Sozzani Tania Azam Philip Bufler Giamila Fantuzzi Igor Goncharov Soo-Hyun Kim Benjamin J Pomerantz Leonid L Reznikov Britta Siegmund Charles A Dinarello Paolo Mascagni

Suberoylanilide hydroxamic acid (SAHA) is a hydroxamic acid-containing hybrid polar molecule; SAHA specifically binds to and inhibits the activity of histone deacetylase. Although SAHA, like other inhibitors of histone deacetylase, exhibits antitumor effects by increasing expression of genes regulating tumor survival, we found that SAHA reduces the production of proinflammatory cytokines in viv...

Journal: :Cancer research 2004
Linda C Hsi Xiaopei Xi Reuben Lotan Imad Shureiqi Scott M Lippman

Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression. HDACs are involved in cell cycle progression and differentiation, and their deregulation is associated with several cancers. HDAC inhibitors have emerged recently as promising chemotherapeutic agents. One such agent, suberoylanilide hydroxamic acid, is a potent inhibit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید